These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26156931)

  • 1. Assessing the Factors Associated With Iran's Intra-Industry Trade in Pharmaceuticals.
    Yusefzadeh H; Hadian M; Abolghasem Gorji H; Ghaderi H
    Glob J Health Sci; 2015 Mar; 7(5):311-9. PubMed ID: 26156931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran.
    Yusefzadeh H; Rezapour A; Lotfi F; Ebadifard Azar F; Nabilo B; Abolghasem Gorji H; Hadian M; Shahidisadeghi N; Karami A
    Glob J Health Sci; 2015 Apr; 7(6):295-307. PubMed ID: 26153184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Iran's
    Aghlmand S; Rahimi B; Farrokh-Eslamlou H; Nabilou B; Yusefzadeh H
    Iran J Pharm Res; 2018; 17(2):822-828. PubMed ID: 29881438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Structure of the World Pharmaceutical Market: Prioritizing Iran's Target Export Markets.
    Shabaninejad H; Yusefzadeh H; Mehralian G; Rahimi B
    Iran J Pharm Res; 2019; 18(1):546-555. PubMed ID: 31089388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Study of Effective Factors on Iran's Pharmaceutical Export Supply and Demand.
    Najafi B; Mahboub-Ahari A; Nouraei Motlagh S; Otobideh SA; Rahimi B; Shabaninejad H; Yusefzadeh H
    Iran J Pharm Res; 2019; 18(4):2226-2232. PubMed ID: 32184887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study.
    Ebadi Fardazar F; Sarabi Asiabar A; Safari H; Asgari M; Saber A; Ebadi Fard Azar AA
    Risk Manag Healthc Policy; 2019; 12():199-208. PubMed ID: 31807100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iran's international collaborative articles in medical sciences.
    Rezaei H; Yousefi A; Larijani B; Dehnavieh R; Rezaei N; Kazemi M; Adibi P
    Med J Islam Repub Iran; 2019; 33():84. PubMed ID: 31696078
    [No Abstract]   [Full Text] [Related]  

  • 8. On the role of government spending, trade openness and terms of trade in Iran's agricultural growth.
    Moghaddasi A; Zeraatkish Y; Moghaddasi R
    Braz J Biol; 2024; 84():e284647. PubMed ID: 39166692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic analysis of Iran's climate resilient health system.
    Mosadeghrad AM; Afshari M; Dehnavi H; Keliddar I; Zahmatkesh M; Isfahani P; Sharifi T; Shahsavani A; Ostadtaghizadeh A; Abbasabadi-Arab M; Yunesian M
    BMC Health Serv Res; 2024 Sep; 24(1):1149. PubMed ID: 39350069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Iranian petroleum crisis and United States national security.
    Stern R
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):377-82. PubMed ID: 17190820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Projection of Iran's Healthcare Expenditures By 2030: Evidence of a Time-Series Analysis.
    Jahanmehr N; Noferesti M; Damiri S; Abdi Z; Goudarzi R
    Int J Health Policy Manag; 2022 Dec; 11(11):2563-2573. PubMed ID: 35174678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2012-2025 Roadmap of I.R.Iran's Disaster Health Management.
    Ardalan A; Rajaei MH; Masoumi G; Azin A; Zonoobi V; Sarvar M; Vaskoei Eshkevari K; Ahmadnezhad E; Jafari G
    PLoS Curr; 2012 Jul; 4():e4f93005fbcb34. PubMed ID: 22953239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the Challenges of Iran's Health Houses and Presenting a Solution.
    Saberi SH; Alimehr M; Amiresmaili M; Seyednezhad M
    Electron Physician; 2016 Oct; 8(10):3122-3126. PubMed ID: 27957313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surprising decline in Iran's growth rates.
    Roudi F
    Popul Today; 1997 Nov; 25(11):4. PubMed ID: 12321257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jordanian pharmaceutical companies: are their marketing efforts paying off?
    Al-Shaikh MS; Torres IM; Zuniga MA; Ghunaim A
    Health Mark Q; 2011 Apr; 28(2):174-89. PubMed ID: 21590563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.
    Setayesh S; Mackey TK
    Global Health; 2016 Jun; 12(1):31. PubMed ID: 27267898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran.
    Safari H; Arab M; Rashidian A; Kebriaee-Zadeh A; Abolghasem Gorji H
    Iran J Pharm Res; 2018; 17(4):1593-1603. PubMed ID: 30568715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel imports and the pricing of pharmaceutical products: evidence from the European Union.
    Ganslandt M; Maskus KE
    J Health Econ; 2004 Sep; 23(5):1035-57. PubMed ID: 15353192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry-level determinants of India's vertical and horizontal IIT.
    Bagchi S; Bhattacharyya S
    Indian Econ Rev; 2021; 56(1):113-145. PubMed ID: 33716313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s].
    Sihn KH
    Uisahak; 2015 Dec; 24(3):749-81. PubMed ID: 26819439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.